Publications by authors named "Norbert Brau"

Claim this Profile
H
Hepatocellular carcinoma in people living with HIV.
Claudia A M Fulgenzi, Alessia Dalla Pria, Alberto Giovanni Leone, Ciro Celsa, Giuseppe Cabibbo, Norbert Brau

J Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of High-Titer Convalescent Plasma on Clinical and Virologic Outcomes Among Veterans Hospitalized With SARS-CoV-2 Infection: VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1).
Edward N Janoff, Mei-Chiung Shih, Curtis Donskey, Ilana Belitskaya-Levy, Norbert Brau

J Med Virol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease Status.
Vincent Lo Re, Craig W Newcomb, Dean M Carbonari, Alyssa K Mezochow, Sean Hennessy

Pharmacoepidemiol Drug Saf· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World Data.
Jessie Torgersen, Alyssa K Mezochow, Craig W Newcomb, Dean M Carbonari, Sean Hennessy

JAMA Intern Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma.
David J Pinato, Takahiro Kaneko, Antonio D'Alessio, Alejandro Forner, Petros Fessas

JHEP Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans.
Harshraj Leuva, Mengxi Zhou, Norbert Brau, Sheldon T Brown, Prabhjot Mundi

Semin Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 in spinal cord injury patients at a veterans administration hospital: A case series.
Marinella D Galea, Michael A Gelman, Vincent P Galea, Krutika Parasar Raulkar, Stephen Kornfeld

J Spinal Cord Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Learning Health System Approach to Long COVID Care.
Allison M Gustavson, Amanda Purnell, Marian Adly, Omar Awan, Norbert Bräu, Nicholas A Braus

Fed Pract· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA).
Ivan O Rosas, Norbert Bräu, Michael Waters, Ronaldo C Go, Atul Malhotra

EClinicalMedicine· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensation.
Jessie Torgersen, Craig W Newcomb, Dean M Carbonari, Christopher T Rentsch, Lesley S Park

J Hepatol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.
Ivan O Rosas, Norbert Bräu, Michael Waters, Ronaldo C Go, Bradley D Hunter

N Engl J Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders.
Michael Fuchs, Alexander Monto, Norbert Bräu, Mariem Charafeddine, Warren Schmidt

J Med Virol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Accuracy of FIB-4 for Cirrhosis in People Living With HIV and Hepatocellular Carcinoma.
Jessie Torgersen, Michael J Kallan, Dean M Carbonari, Lesley S Park, Rajni L Mehta

J Acquir Immune Defic Syndr· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis Status.
Jessie Torgersen, Michael J Kallan, Dena M Carbonari, Lesley S Park, Rajni L Mehta

J Natl Cancer Inst· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to pan-genotypic glecaprevir/pibrentasvir and efficacy in HCV-infected patients: A pooled analysis of clinical trials.
Ashley Brown, Tania M Welzel, Brian Conway, Francesco Negro, Norbert Bräu

Liver Int· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in Pathology, Staging, and Treatment between HIV and Uninfected Patients with Microscopically Confirmed Hepatocellular Carcinoma.
Jessie Torgersen, Tamar H Taddei, Lesley S Park, Dean M Carbonari, Michael J Kallan

Cancer Epidemiol Biomarkers Prev· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study.
David J Pinato, Elias Allara, Ting-Yi Chen, Franco Trevisani, Beatriz Minguez

J Clin Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Group C Streptococcus dysgalactiae subsp.equisimilis (SDSE) Endocarditis with Endogenous Endophthalmitis and Aortic Root Abscess.
Lok Yung, Mahjabeen Rashid, Norbert Bräu

IDCases· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimethod assessment of baseline depression and relationship to hepatitis C treatment discontinuation.
Jeffrey J Weiss, Sarah Prieto, Norbert Bräu, Douglas T Dieterich, Sue M Marcus

Int J Psychiatry Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes.
Zobair M Younossi, Maria Stepanova, Tarik Asselah, Graham Foster, Keyur Patel

Clin Infect Dis· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment.
Edward Gane, Eric Lawitz, David Pugatch, Georgios Papatheodoridis, Norbert Bräu

N Engl J Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study.
David Wyles, Norbert Bräu, Shyam Kottilil, Eric S Daar, Peter Ruane

Clin Infect Dis· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials.
Ira M Jacobson, Eric Lawitz, Edward J Gane, Bernard E Willems, Peter J Ruane

Gastroenterology· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Greater decline in memory and global neurocognitive function in HIV/hepatitis C co-infected than in hepatitis C mono-infected patients treated with pegylated interferon and ribavirin.
Theodore R Miller, Jeffrey J Weiss, Norbert Bräu, Douglas T Dieterich, Alicia Stivala

J Neurovirol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.
Zobair M Younossi, Maria Stepanova, Mark Sulkowski, Graham R Foster, Nancy Reau

Clin Infect Dis· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis